Clobromazolam (also called Phenazolam, BRN 4550445, DM-II-90) is a benzodiazepine derivative with a powerful sedative and hypnotic effect. Clobromazolam was first synthesized in the 1980s, but was not used in medicine and was not approved for sale as a medical remedy. In 2016, this drug was first discovered in Sweden, in samples seized by a laboratory and was designated as a designer drug for chemical research.
Clobromazolam is a derivative of benzodiazepine and has a similar chemical structure.
According to rodent studies, Clobromazolam has been found to act as a powerful sedative and hypnotic agent.
Clobromazolam has an unclear legal status in many countries, including EU countries, but this drug is a controlled drug in Serbia, Italy, Canada, Germany and the United Kingdom.
Clobromazolam is a designer benzodiazepine drug and its toxicological and pharmacological properties are under investigation and not fully understood. This chemical is intended for research and identification of properties, in special rooms, on special laboratory equipment, in compliance with all safety measures.
You can get acquainted with the prices and buy Clobromazolam online right now, at OmniCompound company. We provide all the necessary information about the products and provide a quality guarantee.
| CAS | 87213-50-1 |
| Product Name | Clobromazolam |
| Molecular Formula | C17H12BrClN4 |
| Molecular Weight | 387.7 g/mol |
| IUPAC Name |
8-bromo-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
|
| InChI |
InChI=1S/C17H12BrClN4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3
Key: BUTCFAZTKZDYCN-UHFFFAOYSA-N
SMILES: CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4Cl
|
| Solubility |
|
| Synonyms | Phenazolam, BRN 4550445, DM-II-90 |
| ,Purity | ≥98% |
| Formulation | Soluble |
| Storage | -20°C |
| Stability | ≥ 2 years |
